Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Onduo
Cambridge, Massachusetts, United States
- Ownership
- Private
- Employees
- ~100
- Development stage
- Other
01
Overview
Peer-reviewed clinical studies show significant improvements in glycemic control, blood pressure, cholesterol, and weight among type 2 diabetes patients using Onduo’s virtual care model with intermittent CGM use. For example, high-risk patients experienced an average 2.4% A1C decrease (1.6% average overall), a 4.4 mmHg reduction in systolic blood pressure, a 16.6 mg/dL decrease in total cholesterol, and 9 lb average weight loss over four months.
- Therapeutic areas
- CardiovascularEndocrinology
- Modalities
- DeviceNon-pharmacological therapySoftware
- Industry
- Digital Health Medical Devices
02
Partnerships
Beyond the preview
Go deeper on Onduo.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Onduo.